Delivery Order SPE2DB24D2105-SPE2DB25FAQCJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,129.71. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was awarded without set-aside provisions through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract ceiling value of $1,083.78. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pantoprazole DR 40 mg Suspension Packets (30 count) with a ceiling value of $3,200.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a continuation of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.51 firm fixed-price delivery order is for the supply of 4,562,296,296 units of pantoprazole sodium delayed-release 40 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,856.14, is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in quantities of 1,000. The contract has a firm fixed price and an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.77 firm fixed-price delivery order is for the supply of 4,566,894 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 13, 2025 and is not designated under any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,292.92, is for the delivery of 4,568,174,061 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a firm-fixed-price delivery order, with a performance period extending through May 8, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,841.28, is for the supply of 4,562,828,860 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a period of performance through November 16, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award is for the delivery of 4,555,810 units of Pantoprazole Sodium Delayed-Release tablets (40 mg) to the Defense Logistics Agency (DLA). The $5,981.34 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2021. The contract is a firm-fixed price delivery order with an ultimate completion date of January 3, 2022. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQCJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a 90-count package. This order, valued at $1,120.33, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The award is non-set-aside and was competitively awarded, with performance expected to be completed by August 20, 2025, at the contractor's location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor for federal military and healthcare systems. As a major prime contractor to the Defense Logistics Agency, the company maintains a comprehensive portfolio supplying generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic categories to support Defense Health Agency and military healthcare programs worldwide. The DLA Troop Support Medical contract serves as the overarching vehicle enabling flexible fulfillment of pharmaceutical needs for federal healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/19/25 |